Product
Matching placebo rectal insert
1 clinical trial
1 indication
Indication
Safety IssuesClinical trial
A Double-Blind, Placebo-Controlled, Randomized Phase 1 Study to Evaluate the Safety and Pharmacokinetics of Rectally Administered Tenofovir Alafenamide/Elvitegravir InsertsStatus: Recruiting, Estimated PCD: 2024-10-31